Reduction in mitochondrial iron alleviates cardiac damage during injury
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Excess cellular iron increases reactive oxygen species (ROS) production and causes cellular damage. Mitochondria are the major site of iron metabolism and ROS production; however, few studies have investigated the role of mitochondrial iron in the development of cardiac disorders, such as ischemic heart disease or cardiomyopathy (CM). We observe increased mitochondrial iron in mice after ischemia/reperfusion (I/R) and in human hearts with ischemic CM, and hypothesize that decreasing mitochondrial iron protects against I/R damage and the development of CM. Reducing mitochondrial iron genetically through cardiac‐specific overexpression of a mitochondrial iron export protein or pharmacologically using a mitochondria‐permeable iron chelator protects mice against I/R injury. Furthermore, decreasing mitochondrial iron protects the murine hearts in a model of spontaneous CM with mitochondrial iron accumulation. Reduced mitochondrial ROS that is independent of alterations in the electron transport chain's ROS producing capacity contributes to the protective effects. Overall, our findings suggest that mitochondrial iron contributes to cardiac ischemic damage, and may be a novel therapeutic target against ischemic heart disease. Modulation of mitochondrial iron is shown to be a viable therapeutic approach against ischemic heart disease and heart failure, highlighting the need to develop more targeted iron chelators. Modulation of mitochondrial iron is shown to be a viable therapeutic approach against ischemic heart disease and heart failure, highlighting the need to develop more targeted iron chelators.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
How mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207
ROS function in redox signaling and oxidative stress
Schieber, M., & Chandel, N. S. (2014) · Current Biology · doi:10.1016/j.cub.2014.03.034 · Cited by 6,931 · cited 2×
“The protective effects of reducing mitochondrial iron in both disease models are associated with reduced ROS production during injury.”
BackgroundThe role of iron and reactive oxygen species in cell death
Dixon, S. J., & Stockwell, B. R. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1416 · Cited by 2,381 · cited 1×
“…Medicine Vol 8 | No 3 | 2016 ª 2016 The Authors ª 2016 The Authors EMBO Molecular Medicine Vol 8 | No 3 | 2016 and complex II activities (as observed in ours and other studies (Chen & Zweier, 2014)), and can cause cytochrome C release secondary to AMPK activation (Dixon & Stockwell, 2014).”
BackgroundTwo to tango: Regulation of Mammalian iron metabolism
Hentze, M. W., Muckenthaler, M. U., Galy, B., & Camaschella, C. (2010) · Cell · doi:10.1016/j.cell.2010.06.028 · Cited by 2,120 · cited 1×
“…used for heme and iron/sulfur (Fe/S) cluster synthesis in mitochondria or is stored in ferritin molecules in the cytoplasm (De Domenico et al, 2008; Hentze et al, 2010; Ye & Rouault, 2010) or in mitochondrial ferritin molecules in mitochondria (Napier et al, 2005; Horowitz & Greenamyre, 2010;…”
MethodFerric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
Anker, S. D., Comin Colet, J., Filippatos, G., Willenheimer, R., Dickstein, K., Drexler, H., Lüscher, T. F., Bart, B., Banasiak, W., Niegowska, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908355 · Cited by 2,083
The Role of Dynamin-Related Protein 1, a Mediator of Mitochondrial Fission, in Apoptosis
Frank, S., Gaume, B., Bergmann-Leitner, E. S., Leitner, W. W., Robert, E. G., Catez, F., Smith, C. L., & Youle, R. J. (2001) · Developmental Cell · doi:10.1016/s1534-5807(01)00055-7 · Cited by 1,755 · cited 1×
“…biogenesis or NOS expression Mitochondrial dynamics have been shown to be associated with mitochondrial ROS production (Pletjushkina et al, 2006; Jheng et al, 2012), and the mitochondrial fission protein dynamin-related protein 1 (Drp1) has been linked to apoptosis (Frank et al, 2001).”
BackgroundJheng, H.-F., Tsai, P.-J., Guo, S.-M., Kuo, L.-H., Chang, C.-S., Su, I.-J., Chang, C.-R., & Tsai, Y.-S. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.05603-11 · Cited by 650 · cited 1×
“…biogenesis or NOS expression Mitochondrial dynamics have been shown to be associated with mitochondrial ROS production (Pletjushkina et al, 2006; Jheng et al, 2012), and the mitochondrial fission protein dynamin-related protein 1 (Drp1) has been linked to apoptosis (Frank et al, 2001).”
BackgroundThe inactivation of Fe-S cluster containing hydro-lyases by superoxide
Flint, D. H., Tuminello, J. F., & Emptage, M. H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41538-4 · Cited by 637
Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury
Adlam, V. J., Harrison, J. C., Porteous, C. M., James, A. M., Smith, R. A. J., Murphy, M. P., & Sammut, I. A. (2005) · The FASEB Journal · doi:10.1096/fj.05-3718com · Cited by 618 · cited 1×
“…cardiovascular disease and cancer (Jha et al, 1995; Steinhubl, 2008; Fortmann et al, 2013), recent animal studies and human trials using mitochondria-targeted antioxidants have offered promising results (Adlam et al, 2005; Neuzil et al, 2007; Xu et al, 2008; Gane et al, 2010; Dai et al, 2011).”
Regulation of iron acquisition and storage: consequences for iron-linked disorders
De Domenico, I., McVey Ward, D., & Kaplan, J. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2295 · Cited by 464 · cited 1×
“Normally, iron is used for heme and iron/sulfur (Fe/S) cluster synthesis in mitochondria or is stored in ferritin molecules in the cytoplasm (De Domenico et al, 2008; Hentze et al, 2010; Ye & Rouault, 2010) or in mitochondrial ferritin molecules in mitochondria (Napier et al, 2005; Horowitz &…”
BackgroundFortmann, S. P., Burda, B. U., Senger, C. A., Lin, J. S., & Whitlock, E. P. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-12-201312170-00729 · Cited by 442 · cited 1×
“…antioxidants did not show benefits in different disease settings, including cardiovascular disease and cancer (Jha et al, 1995; Steinhubl, 2008; Fortmann et al, 2013), recent animal studies and human trials using mitochondria-targeted antioxidants have offered promising results (Adlam et al,…”
BackgroundEaton, J. W., & Qian, M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00772-4 · Cited by 389 · cited 1×
“Additionally, in diseases with mitochondrial iron overload, ironmediated mitochondrial DNA and membrane damage have been linked to mitochondrial dysfunction (Eaton & Qian, 2002; Gao et al, 2009).”
BackgroundGane, E. J., Weilert, F., Orr, D. W., Keogh, G. F., Gibson, M., Lockhart, M. M., Frampton, C. M., Taylor, K. M., Smith, R. A. J., & Murphy, M. P. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02250.x · Cited by 379 · cited 1×
“…cardiovascular disease and cancer (Jha et al, 1995; Steinhubl, 2008; Fortmann et al, 2013), recent animal studies and human trials using mitochondria-targeted antioxidants have offered promising results (Adlam et al, 2005; Neuzil et al, 2007; Xu et al, 2008; Gane et al, 2010; Dai et al, 2011).”
Mitochondrial iron metabolism and its role in neurodegeneration
Horowitz, M. P., & Greenamyre, J. T. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100354 · Cited by 195 · cited 1×
“…cluster synthesis in mitochondria or is stored in ferritin molecules in the cytoplasm (De Domenico et al, 2008; Hentze et al, 2010; Ye & Rouault, 2010) or in mitochondrial ferritin molecules in mitochondria (Napier et al, 2005; Horowitz & Greenamyre, 2010; Vigani et al, 2013; Li et al, 2014).”
BackgroundPathways underlying iron accumulation in human nonalcoholic fatty liver disease
Aigner, E., Theurl, I., Theurl, M., Lederer, D., Haufe, H., Dietze, O., Strasser, M., Datz, C., & Weiss, G. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.5.1374 · Cited by 190 · cited 1×
“Excess iron can cause tissue damage through the production of reactive oxygen species (ROS) via the Fenton-like and Harbor–Weiss reactions (Aigner et al, 2008).”
BackgroundRauen, U., Springer, A., Weisheit, D., Petrat, F., Korth, H., de Groot, H., & Sustmann, R. (2007) · ChemBioChem · doi:10.1002/cbic.200600311 · Cited by 121 · cited 1×
“Mitochondria contain 10–20 lM of labile iron, but the exact concentration can vary from organ to organ (Petrat et al, 2002a; Rauen et al, 2007).”
BackgroundDemougeot, C., Van Hoecke, M., Bertrand, N., Prigent-Tessier, A., Mossiat, C., Beley, A., & Marie, C. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.072744 · Cited by 73 · cited 3×
“We chose two iron chelators with distinct mitochondrial permeability—DFO, which has poor penetrance through the cell membrane, and BPD, which has high membrane permeability and thus is able to access mitochondria (Demougeot et al, 2004).”
Background
Cited by
Iron Metabolism in Ferroptosis
Chen, X., Yu, C., Kang, R., & Tang, D. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.590226 · Cited by 959
Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies
Zhou, Q., Meng, Y., Li, D., Yao, L., Le, J., Liu, Y., Sun, Y., Zeng, F., Chen, X., & Deng, G. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01769-5 · Cited by 890
Iron Homeostasis and Ferroptosis in Human Diseases: Mechanisms and Therapeutic Prospects
Ru, Q., Li, Y., Chen, L., Wu, Y., Min, J., & Wang, F. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01969-z · Cited by 724
Ferritinophagy-mediated ferroptosis is involved in sepsis-induced cardiac injury
Li, N., Wang, W., Zhou, H., Wu, Q., Duan, M., Liu, C., Wu, H., Deng, W., Shen, D., & Tang, Q. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.08.009 · Cited by 669
Oxidative Stress: Signaling Pathways, Biological Functions, and Disease
Liu, S., Liu, J., Wang, Y., Deng, F., & Deng, Z. (2025) · MedComm · doi:10.1002/mco2.70268 · Cited by 359
Metadata
- Authors
- Chang, H., Wu, R., Shang, M., Sato, T., Chen, C., Shapiro, J. S., Liu, T., Thakur, A., Sawicki, K. T., Prasad, S. V., & Ardehali, H.
- Venue
- EMBO Molecular Medicine
- Published
- 2016-02-19
- Volume
- 8
- Issue
- 3
- Pages
- 247-267
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- OpenAlex
- W2275746735
- Cited by
- 138
- References
- 17
- FWCI
- 5.47
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.